TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/9/24 17:31 | 1/5/24 | COEP | Coeptis Therapeutics Holdings, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Salkind Gene | PA | D | P | 8 | 0.6900 | 0 | 12 | 4 | 317 | D | |||||||||||||||
8/30/23 15:15 | 8/25/23 | COEP | Coeptis Therapeutics Holdings, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Salkind Gene | PA | D | P.m | 30 | 0.9223 | 0 | 33 | 15 | 254 | I | |||||||||||||||
4/1/22 14:42 | 3/30/22 | GRVI | Grove, Inc. | NV | Health | MdCm | Medicinal Chemicals & Botanic | Salkind Gene | NV | DT | P.d | 500 | 4.00 | 0 | 125 | 5 | 2,478 | I | |||||||||||||||
10/4/21 19:30 | 9/30/21 | MOBQ | Mobiquity Technologies, Inc. | NY | BizSv | Ads | Advertising | Salkind Gene | NY | DT | M.d | 0 | 0.00 | 0 | 375 | 51 | 1,116 | D | |||||||||||||||
1/21/20 13:18 | 9/13/19 | MOBQ | Mobiquity Technologies, Inc. | NY | BizSv | Ads | Advertising | Salkind Gene | NY | DT | P.ad | 3,195 | 0.0183 | 0 | 175,000 | 192 | 266,318 | D | |||||||||||||||
1/3/20 16:17 | 12/31/19 | DMTK | Dermtech, Inc. | Health | Health | Medical Laboratories | Salkind Gene | CA | D | M.d | 0 | 0.00 | 0 | 8 | 5 | 173 | D | ||||||||||||||||
9/19/19 13:49 | 9/13/19 | MOBQ | Mobiquity Technologies, Inc. | NY | BizSv | Ads | Advertising | Salkind Gene | NY | DT | P.d | 3,195 | 0.0183 | 0 | 175,000 | 192 | 266,318 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |